Literature DB >> 18401556

Endothelial nitric oxide synthase gene haplotypes and diabetic nephropathy among Asian Indians.

Tarunveer Singh Ahluwalia1, Monica Ahuja, Taranjit Singh Rai, Harbir Singh Kohli, Kamal Sud, Anil Bhansali, Madhu Khullar.   

Abstract

Endothelial dysfunction plays a key role in the pathogenesis of diabetic vascular disease, including diabetic nephropathy. Endothelial-derived nitric oxide synthase (eNOS) gene polymorphisms affect eNOS activity and are associated with endothelial dysfunction. We evaluated the association of the constitutive endothelial nitric oxide synthase gene (eNOS) polymorphisms with type 2 diabetic nephropathy. We genotyped three polymorphisms of eNOS (Two SNPs: -786T > C, 894G > T and one 27-bp repeat polymorphism in Intron 4 (27VNTR)) in type 2 diabetic nephropathy patients (cases: n = 195) and type 2 diabetic without nephropathy (controls: n = 255), using validated PCR-RFLP assays. We measured serum NO levels in these subjects and examined its correlation with diabetic nephropathy and eNOS genotypes. The frequency of CC (-786T > C), TT (894G > T) and aa genotypes (27VNTR) were significantly higher in diabetic nephropathy patients as compared to the diabetes without nephropathy group (CC: P = 0.003, TT: P = 0.03, aa: P < 0.0001). These mutant genotypes were found to be associated with higher risk of nephropathy (-786T > C: OR: 5.5, 95%CI: 1.53-19.79; 894G > T: OR: 1.8, 95%CI: 1.03-3.16; Intron 4: OR: 6.23, 95%CI: 2.23-16.31). Haplotype with all the wild alleles (T-b-G) was found to be associated with a decreased risk of nephropathy (OR: 0.68, P = 0.005) and haplotype with all mutant alleles (C-a-T) was associated with higher risk of diabetic nephropathy as compared to diabetes without nephropathy group (OR: 2.6, P = 0.14). No significant linkage disequilibria were observed among the variants in this case-control study. The serum NO levels were observed to be significantly (P < 0.05) lower in mutant allele carriers ('C' allele of T-786C SNP and/or 'T' allele of G894T SNP) as compared with the wild-type allele carriers (-786T and/or 894G) within each of the subject groups (with and without nephropathy). These results suggest that the eNOS gene locus is associated with diabetic nephropathy and the functional polymorphisms (-786T > C &amp; 894G > T) might lead to a decreased expression of eNOS gene.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18401556     DOI: 10.1007/s11010-008-9759-8

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  52 in total

1.  The future of association studies: gene-based analysis and replication.

Authors:  Benjamin M Neale; Pak C Sham
Journal:  Am J Hum Genet       Date:  2004-07-22       Impact factor: 11.025

2.  eNOS G894T polymorphism as a mild predisposing factor for abdominal aortic aneurysm.

Authors:  Cinzia Fatini; Francesco Sofi; Elena Sticchi; Paola Bolli; Ilaria Sestini; Michela Falciani; Leonidas Azas; Giovanni Pratesi
Journal:  J Vasc Surg       Date:  2005-09       Impact factor: 4.268

3.  T-786-->C mutation in the 5'-flanking region of the endothelial nitric oxide synthase gene is associated with coronary spasm.

Authors:  M Nakayama; H Yasue; M Yoshimura; Y Shimasaki; K Kugiyama; H Ogawa; T Motoyama; Y Saito; Y Ogawa; Y Miyamoto; K Nakao
Journal:  Circulation       Date:  1999-06-08       Impact factor: 29.690

4.  Association of the missense Glu298Asp variant of the endothelial nitric oxide synthase gene with severe preeclampsia.

Authors:  T Yoshimura; M Yoshimura; A Tabata; Y Shimasaki; M Nakayama; Y Miyamoto; Y Saito; K Nakao; H Yasue; H Okamura
Journal:  J Soc Gynecol Investig       Date:  2000 Jul-Aug

5.  Association of the nitric oxide synthase gene polymorphism with an increased risk for progression to diabetic nephropathy in type 2 diabetes.

Authors:  S Neugebauer; T Baba; T Watanabe
Journal:  Diabetes       Date:  2000-03       Impact factor: 9.461

6.  T(-786)-->C polymorphism of the endothelial nitric oxide synthase gene influences the progression of renal disease.

Authors:  Yukiteru Asakimori; Noriaki Yorioka; Yoshihiko Taniguchi; Takafumi Ito; Satoshi Ogata; Yasufumi Kyuden; Nobuoki Kohno
Journal:  Nephron       Date:  2002-08       Impact factor: 2.847

7.  Association of eNOS Glu298Asp polymorphism with end-stage renal disease.

Authors:  Eisei Noiri; Hiroaki Satoh; Jun-ichi Taguchi; Sergey V Brodsky; Akihide Nakao; Yumiko Ogawa; Satomi Nishijima; Takehiko Yokomizo; Katsushi Tokunaga; Toshiro Fujita
Journal:  Hypertension       Date:  2002-10       Impact factor: 10.190

8.  A smoking-dependent risk of coronary artery disease associated with a polymorphism of the endothelial nitric oxide synthase gene.

Authors:  X L Wang; A S Sim; R F Badenhop; R M McCredie; D E Wilcken
Journal:  Nat Med       Date:  1996-01       Impact factor: 53.440

9.  Race-specific differences in endothelial function: predisposition of African Americans to vascular diseases.

Authors:  Leszek Kalinowski; Iwona T Dobrucki; Tadeusz Malinski
Journal:  Circulation       Date:  2004-05-24       Impact factor: 29.690

10.  Endothelial nitric oxide synthase gene [G894T] polymorphism as a possible risk factor in aneurysmal subarachnoid haemorrhage.

Authors:  U Ozüm; N Bolat; E Gül; O Ozdemir
Journal:  Acta Neurochir (Wien)       Date:  2007-11-30       Impact factor: 2.216

View more
  20 in total

1.  Interaction of eNOS polymorphism with MTHFR variants increase the risk of diabetic nephropathy and its progression in type 2 diabetes mellitus patients.

Authors:  Yazdan Jafari; Zohreh Rahimi; Asad Vaisi-Raygani; Mansour Rezaei
Journal:  Mol Cell Biochem       Date:  2011-03-06       Impact factor: 3.396

Review 2.  Association of genetic variants with diabetic nephropathy.

Authors:  Saliha Rizvi; Syed Tasleem Raza; Farzana Mahdi
Journal:  World J Diabetes       Date:  2014-12-15

3.  Genetic studies of nephrotic syndrome in Egyptian children.

Authors:  Rehab Elmougy
Journal:  J Appl Biomed       Date:  2021-10-12       Impact factor: 1.797

4.  NOS3 rs1799983 and rs2070744 polymorphisms and their association with advanced chronic kidney disease and coronary heart disease in Canarian population with type 2 diabetes.

Authors:  M Boronat; A Tugores; P Saavedra; P Garay; E Bosch; D Lorenzo; A Ibarra; C García-Cantón
Journal:  Acta Endocrinol (Buchar)       Date:  2021 Oct-Dec       Impact factor: 1.104

Review 5.  Endothelial Dysfunction in Type 2 Diabetes Mellitus.

Authors:  R Dhananjayan; K S Srivani Koundinya; T Malati; Vijay Kumar Kutala
Journal:  Indian J Clin Biochem       Date:  2015-09-29

Review 6.  Renal endothelial dysfunction in diabetic nephropathy.

Authors:  Huifang Cheng; Raymond C Harris
Journal:  Cardiovasc Hematol Disord Drug Targets       Date:  2014

Review 7.  Acute Kidney Injury and Progression of Diabetic Kidney Disease.

Authors:  Samuel Mon-Wei Yu; Joseph V Bonventre
Journal:  Adv Chronic Kidney Dis       Date:  2018-03       Impact factor: 3.620

Review 8.  A meta-analysis of three polymorphisms in the endothelial nitric oxide synthase gene (NOS3) and their effect on the risk of diabetic nephropathy.

Authors:  Zhen Zeng; Lina Li; Zhao Zhang; Yang Li; Zhiyun Wei; Ke Huang; Lin He; Yongyong Shi
Journal:  Hum Genet       Date:  2010-01-05       Impact factor: 4.132

9.  Association between genetic polymorphisms of ACE & eNOS and diabetic nephropathy.

Authors:  P Huo; D Zhang; X Guan; Y Mei; H Zheng; X Feng
Journal:  Mol Biol Rep       Date:  2014-09-17       Impact factor: 2.316

10.  Endothelial nitric oxide synthase gene polymorphism (G894T) and diabetes mellitus (type II) among South Indians.

Authors:  T Angeline; H R Krithiga; W Isabel; A J Asirvatham; A Poornima
Journal:  Oxid Med Cell Longev       Date:  2011-11-09       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.